Published on 8 Aug 2021 on Benzinga
The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The...
Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader markets. Earnings continued to flow in, triggering stock-specific moves, while clinical readouts also moved stocks during the week.
BeyondSpring Inc. (NASDAQ: BYSI) was among the biggest biopharma gainers of the week, with the stock reacting to a positive late-stage readout for its lung cancer treatment combo. The stock ended the week with a gain of about 128%.
NASDAQ.RETA price evolution
NASDAQ.APTX price evolution
NASDAQ.AMPH price evolution
NASDAQ.ACHV price evolution
NASDAQ.VIRI price evolution
NASDAQ.PDSB price evolution
NASDAQ.ADMA price evolution
NASDAQ.ONTX price evolution
NASDAQ.APLT price evolution
NASDAQ.APLS price evolution
NASDAQ.AGEN price evolution
NASDAQ.DARE price evolution
NASDAQ.EVFM price evolution
NASDAQ.AFIB price evolution
NASDAQ.RPRX price evolution
NASDAQ.ATRA price evolution
NASDAQ.AVDL price evolution
NASDAQ.BLUE price evolution
NASDAQ.BYSI price evolution
NASDAQ.CARA price evolution
NASDAQ.BNTX price evolution
NASDAQ.INO price evolution
NASDAQ.XGN price evolution
NASDAQ.ORGO price evolution
NASDAQ.RUBY price evolution
NYSE.AMRX price evolution
NYSE.ELAN price evolution
NASDAQ.BIOL price evolution
NASDAQ.VTRS price evolution
NASDAQ.NVAX price evolution
Want to become a better investor?
Start tracking your investments with Statfolio
Sign up for free